FOCIS is the meeting in translational immunology that will give you a competitive edge in your career. Stay ahead of the curve with leading clinicians and researchers delivering the latest breakthroughs across immune-mediated diseases. Focusing on molecular pathways and their implications in human disease provides the unique opportunity for innovative thinking and apply ideas from the pathologies of other diseases to uncover novel solutions to challenges in the diseases you study.
FOCIS delegates range in specialties including, but not limited to autoimmunity, diabetes, allergy/asthma, transplantation,rheumatology, genetics and neurology, reflecting the diverse and interdisciplinary culture of FOCIS.
FOCIS 2018 offers the opportunity for manufacturers, distributors and suppliers of products that relate to translational immunology to showcase their products/services.
• Complimentary registration to FOCIS 2018 scientific sessions
• Exhibitor suite upgrades available: Hold private meetings with Key Opinion Leaders throughout FOCIS 2018
• Social media promotion connecting exhibitors with the FOCIS audience
The Federation of Clinical Immunology Societies (FOCIS) exists to improve human health through immunology by fostering interdisciplinary approaches to both understand and treat immune-based diseases. Initially established as a cross-disciplinary meeting, FOCIS held its first Annual Meeting in 2001. After two successful consecutive meetings, FOCIS incorporated in 2003 as a 501(c)3 organization. Now in its twelfth year of existence, FOCIS has 53 Member Societies, representing roughly 65,000 clinician scientists. A Federation of this size provides a voice for clinical immunologists and ultimately strives to improve patient care.
Chief, Laboratory of Systems Biology
NIAID, National Institutes of Health
Ronald N. Germain received his M.D. and Ph.D. from Harvard University in 1976 Since that time he has investigated basic immunobiology, first on the faculty of Harvard Medical School and, since 1982, as the Chief, Lymphocyte Biology Section in the Laboratory of Immunology and now as Chief of the Laboratory of Systems Biology at NIAID, NIH. He and his colleagues have made key contributions to our understanding of MHC class II molecule structureâ€“function relationships, the cell biology of antigen processing, and the molecular basis of T cell recognition. More recently, his laboratory has explored the relationship between immune tissue organization and control of immunity studied using dynamic and static in situ microscopic methods that his laboratory helped pioneer. He has published more than 300 scholarly research papers and reviews.
Among numerous honors, he was elected as an Associate (foreign) member of EMBO (2008), elected to the National Academy of Medicine, National Academy of Sciences USA (2013), received the Meritorious Career Award from the American Association of Immunologists (2015), chosen as NIAID Outstanding Mentor (2016), elected to the National Academy of Sciences (2016) and has been designated an NIH Distinguished Investigator. He has trained more than 70 postdoctoral fellows, many of whom hold senior academic and administrative positions at leading universities and medical schools
Columbia Center for Translational Immunology, Department of Medicine, Columbia University